16-85918797-T-G
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_002163.4(IRF8):āc.982T>Gā(p.Phe328Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000574 in 1,608,366 control chromosomes in the GnomAD database, including 7 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_002163.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
IRF8 | NM_002163.4 | c.982T>G | p.Phe328Val | missense_variant | 7/9 | ENST00000268638.10 | NP_002154.1 | |
IRF8 | NM_001363907.1 | c.1012T>G | p.Phe338Val | missense_variant | 7/9 | NP_001350836.1 | ||
IRF8 | NM_001363908.1 | c.370T>G | p.Phe124Val | missense_variant | 5/7 | NP_001350837.1 | ||
IRF8 | XM_047434052.1 | c.1012T>G | p.Phe338Val | missense_variant | 8/10 | XP_047290008.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IRF8 | ENST00000268638.10 | c.982T>G | p.Phe328Val | missense_variant | 7/9 | 1 | NM_002163.4 | ENSP00000268638.4 |
Frequencies
GnomAD3 genomes AF: 0.000466 AC: 71AN: 152252Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000947 AC: 232AN: 244972Hom.: 4 AF XY: 0.00122 AC XY: 162AN XY: 133254
GnomAD4 exome AF: 0.000587 AC: 854AN: 1455996Hom.: 7 Cov.: 31 AF XY: 0.000752 AC XY: 545AN XY: 724672
GnomAD4 genome AF: 0.000459 AC: 70AN: 152370Hom.: 0 Cov.: 33 AF XY: 0.000523 AC XY: 39AN XY: 74508
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:2
Likely benign, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Oct 01, 2017 | - - |
Likely benign, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, University Medical Center Utrecht | - | - - |
Mendelian susceptibility to mycobacterial diseases due to partial IRF8 deficiency;C4016741:Immunodeficiency 32B Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 19, 2024 | - - |
IRF8-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jun 05, 2020 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at